NCI-H441 Cells in Surfactant Regulation Research
Key Takeaways:
- NCI-H441 cells serve as a premier model for studying pulmonary surfactant production and regulation
- These cells express key surfactant proteins crucial for alveolar function and respiratory homeostasis
- NCI-H441 cells enable research on lung development, ARDS, and respiratory distress syndrome
- Cytion's NCI-H441 cell line maintains high viability and authentic expression patterns
- Applications span from basic respiratory science to pharmaceutical development for pulmonary disorders
The human pulmonary epithelial NCI-H441 cell line has become an indispensable tool in respiratory research, particularly for studies focused on surfactant regulation and production. At Cytion, we've optimized the cultivation and characterization of these cells to provide researchers with a reliable model system that closely mimics the physiological functions of Clara cells and type II pneumocytes in the human lung.
NCI-H441 Cells in Surfactant Regulation Research
NCI-H441 cells serve as a premier model for studying pulmonary surfactant production and regulation in the human respiratory system. Derived from a human lung papillary adenocarcinoma, these cells exhibit characteristics of both Clara cells and Type II alveolar epithelial cells, making them invaluable for investigating the complex mechanisms of surfactant protein expression and secretion. At Cytion, our NCI-H441 Cells are meticulously cultured to maintain these critical functional properties, providing researchers with a reliable and reproducible model system for respiratory research.
Surfactant Protein Expression Profile
These cells express key surfactant proteins crucial for alveolar function and respiratory homeostasis. NCI-H441 cells synthesize surfactant proteins A, B, C, and D (SP-A, SP-B, SP-C, and SP-D), with particularly robust expression of SP-A and SP-B under appropriate culture conditions. These proteins are essential for reducing surface tension at the air-liquid interface in alveoli, preventing collapse during respiration, and contributing to innate immunity within the lung. Our research team at Cytion has optimized culture protocols to enhance the expression of these surfactant proteins, allowing researchers to study their regulation under various physiological and pathological conditions, including inflammation, hypoxia, and exposure to environmental toxins.
Applications in Respiratory Disease Research
NCI-H441 cells enable research on lung development, ARDS, and respiratory distress syndrome through their faithful recapitulation of type II pneumocyte function. As a vital component of our lung cancer cell lines collection, these cells serve as an excellent model for investigating the pathogenesis of acute lung injury and the molecular mechanisms underlying surfactant dysfunction. Researchers utilizing our NCI-H441 Cells have made significant advances in understanding neonatal respiratory distress syndrome, where insufficient surfactant production leads to life-threatening breathing difficulties in premature infants. Additionally, these cells provide valuable insights into adult ARDS pathophysiology, allowing for the testing of potential therapeutic interventions that might restore proper surfactant function or protect alveolar epithelial integrity during inflammatory conditions.
NCI-H441 Cell Line: Key Features and Applications
Quality and Reliability of Cytion's NCI-H441 Cells
Cytion's NCI-H441 cell line maintains high viability and authentic expression patterns through our rigorous quality control standards and specialized culture techniques. Each batch of our NCI-H441 Cells undergoes comprehensive authentication testing to verify genetic identity and is certified mycoplasma-free via our Mycoplasma testing service. We optimize culture conditions to ensure consistent surfactant protein expression, with cells maintaining over 95% viability upon delivery when handled according to our protocols. Our specialized RPMI 1640 culture medium formulation supports the distinctive Clara cell and type II pneumocyte characteristics that make these cells invaluable for respiratory research. Researchers can further verify the authenticity of these cells through our Cell line authentication - Human service, ensuring experimental reproducibility and reliable research outcomes.
Research and Therapeutic Applications
Applications span from basic respiratory science to pharmaceutical development for pulmonary disorders, positioning NCI-H441 cells as a versatile platform across the respiratory research spectrum. In fundamental science, these cells help elucidate the molecular mechanisms governing surfactant protein gene expression and secretion pathways. For translational research, they serve as effective screening tools for evaluating novel therapeutics targeting conditions like idiopathic pulmonary fibrosis, COPD, and cystic fibrosis. Pharmaceutical companies leverage our NCI-H441 cells to test drug delivery systems designed for pulmonary administration, assess potential pulmonary toxicity of new compounds, and develop treatments for surfactant deficiency disorders. The cells' response to glucocorticoids—which enhance surfactant production—makes them particularly valuable for developing and optimizing anti-inflammatory therapies for respiratory conditions. As respiratory diseases continue to present significant global health challenges, Cytion's NCI-H441 cell line remains an essential resource for researchers seeking to advance our understanding and treatment of these disorders.